Article

The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitors

2023-05-25

Abstract excerpt

Emerging evidence supports the important role of the tumor microbiome in oncogenesis, cancer immune phenotype, cancer progression, and treatment outcomes in many malignancies. In this study, we investigated the metastatic melanoma tumor microbiome and potential roles in association with clinical outcomes, such as survival, in patients with metastatic disease treated with immune checkpoint inhibitors (ICIs). Baseli...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e8a787fc-a498-565e-8d42-0680a17c139a
DOI: 10.1101/2023.05.24.542123

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The tumor microbiome as a predictor of outcomes in patients with metastatic melanoma treated with immune checkpoint inhibitorsDOI 10.1101/2023.05.24.542123Read

Taxonomy-free fecal microbiome profiles enable robust prediction of immunotherapy response and toxicity in melanomaSemantic proximity Read

A pan-cancer analysis of the microbiome in metastatic cancerSemantic proximity Read

Integrative Multi-Omics Analysis of Melanoma: Uncovering Pathways Associated with Immunotherapy OutcomesSemantic proximity Read

Bacteroides vulgatus and Bacteroides dorei predict immune-related adverse events in immune checkpoint blockade treatment of metastatic melanomaSemantic proximity Read

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanomaSemantic proximity Read

Melanoma and microbiota: Current understanding and future directionsSemantic proximity Read

The gut microbiome and melanoma: A reviewSemantic proximity Read

Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway InhibitionSemantic proximity Read

Association of gut microbiota and immune gene expression with response to targeted therapy in BRAF mutated melanomaSemantic proximity Read

Systemic metabolic depletion of gut microbiome undermines responsiveness to melanoma immunotherapySemantic proximity Read

Meta-analytic microbiome target discovery for immune checkpoint inhibitor response in advanced melanomaSemantic proximity Read

Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patientsSemantic proximity Read